Cargando…

Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS

Complex regional pain syndrome (CRPS) is a chronic, debilitating pain condition that usually arises after trauma to a limb, but its precise etiology remains elusive. Novel clinical signs based on body perceptual disturbances have been reported, but their pathophysiological mechanisms remain poorly u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuttikat, Anoop, Noreika, Valdas, Shenker, Nicholas, Chennu, Srivas, Bekinschtein, Tristan, Brown, Christopher Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728301/
https://www.ncbi.nlm.nih.gov/pubmed/26858626
http://dx.doi.org/10.3389/fnhum.2016.00016
_version_ 1782412082543591424
author Kuttikat, Anoop
Noreika, Valdas
Shenker, Nicholas
Chennu, Srivas
Bekinschtein, Tristan
Brown, Christopher Andrew
author_facet Kuttikat, Anoop
Noreika, Valdas
Shenker, Nicholas
Chennu, Srivas
Bekinschtein, Tristan
Brown, Christopher Andrew
author_sort Kuttikat, Anoop
collection PubMed
description Complex regional pain syndrome (CRPS) is a chronic, debilitating pain condition that usually arises after trauma to a limb, but its precise etiology remains elusive. Novel clinical signs based on body perceptual disturbances have been reported, but their pathophysiological mechanisms remain poorly understood. Investigators have used functional neuroimaging techniques (including MEG, EEG, fMRI, and PET) to study changes mainly within the somatosensory and motor cortices. Here, we provide a focused review of the neuroimaging research findings that have generated insights into the potential neurocognitive and neuroplastic mechanisms underlying perceptual disturbances in CRPS. Neuroimaging findings, particularly with regard to somatosensory processing, have been promising but limited by a number of technique-specific factors (such as the complexity of neuroimaging investigations, poor spatial resolution of EEG/MEG, and use of modeling procedures that do not draw causal inferences) and more general factors including small samples sizes and poorly characterized patients. These factors have led to an underappreciation of the potential heterogeneity of pathophysiology that may underlie variable clinical presentation in CRPS. Also, until now, neurological deficits have been predominantly investigated separately from perceptual and cognitive disturbances. Here, we highlight the need to identify neurocognitive phenotypes of patients with CRPS that are underpinned by causal explanations for perceptual disturbances. We suggest that a combination of larger cohorts, patient phenotyping, the use of both high temporal, and spatial resolution neuroimaging methods, and the identification of simplified biomarkers is likely to be the most fruitful approach to identifying neurocognitive phenotypes in CRPS. Based on our review, we explain how such phenotypes could be characterized in terms of hierarchical models of perception and corresponding disturbances in recurrent processing involving the somatosensory, salience and executive brain networks. We also draw attention to complementary neurological factors that may explain some CRPS symptoms, including the possibility of central neuroinflammation and neuronal atrophy, and how these phenomena may overlap but be partially separable from neurocognitive deficits.
format Online
Article
Text
id pubmed-4728301
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-47283012016-02-08 Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS Kuttikat, Anoop Noreika, Valdas Shenker, Nicholas Chennu, Srivas Bekinschtein, Tristan Brown, Christopher Andrew Front Hum Neurosci Neuroscience Complex regional pain syndrome (CRPS) is a chronic, debilitating pain condition that usually arises after trauma to a limb, but its precise etiology remains elusive. Novel clinical signs based on body perceptual disturbances have been reported, but their pathophysiological mechanisms remain poorly understood. Investigators have used functional neuroimaging techniques (including MEG, EEG, fMRI, and PET) to study changes mainly within the somatosensory and motor cortices. Here, we provide a focused review of the neuroimaging research findings that have generated insights into the potential neurocognitive and neuroplastic mechanisms underlying perceptual disturbances in CRPS. Neuroimaging findings, particularly with regard to somatosensory processing, have been promising but limited by a number of technique-specific factors (such as the complexity of neuroimaging investigations, poor spatial resolution of EEG/MEG, and use of modeling procedures that do not draw causal inferences) and more general factors including small samples sizes and poorly characterized patients. These factors have led to an underappreciation of the potential heterogeneity of pathophysiology that may underlie variable clinical presentation in CRPS. Also, until now, neurological deficits have been predominantly investigated separately from perceptual and cognitive disturbances. Here, we highlight the need to identify neurocognitive phenotypes of patients with CRPS that are underpinned by causal explanations for perceptual disturbances. We suggest that a combination of larger cohorts, patient phenotyping, the use of both high temporal, and spatial resolution neuroimaging methods, and the identification of simplified biomarkers is likely to be the most fruitful approach to identifying neurocognitive phenotypes in CRPS. Based on our review, we explain how such phenotypes could be characterized in terms of hierarchical models of perception and corresponding disturbances in recurrent processing involving the somatosensory, salience and executive brain networks. We also draw attention to complementary neurological factors that may explain some CRPS symptoms, including the possibility of central neuroinflammation and neuronal atrophy, and how these phenomena may overlap but be partially separable from neurocognitive deficits. Frontiers Media S.A. 2016-01-27 /pmc/articles/PMC4728301/ /pubmed/26858626 http://dx.doi.org/10.3389/fnhum.2016.00016 Text en Copyright © 2016 Kuttikat, Noreika, Shenker, Chennu, Bekinschtein and Brown. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Kuttikat, Anoop
Noreika, Valdas
Shenker, Nicholas
Chennu, Srivas
Bekinschtein, Tristan
Brown, Christopher Andrew
Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title_full Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title_fullStr Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title_full_unstemmed Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title_short Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS
title_sort neurocognitive and neuroplastic mechanisms of novel clinical signs in crps
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728301/
https://www.ncbi.nlm.nih.gov/pubmed/26858626
http://dx.doi.org/10.3389/fnhum.2016.00016
work_keys_str_mv AT kuttikatanoop neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps
AT noreikavaldas neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps
AT shenkernicholas neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps
AT chennusrivas neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps
AT bekinschteintristan neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps
AT brownchristopherandrew neurocognitiveandneuroplasticmechanismsofnovelclinicalsignsincrps